The current valuation score of Avidity Biosciences Inc is 8.75, ranking 50 out of 158 in the Pharmaceuticals industry. Its current P/E ratio is -4.66, which is -65.11% below the recent high of -1.63 and -321.92% above the recent low of -19.66.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.